GT Biopharma GTBP
NASDAQ GTBP
$6.20 -0.27 (-4.17%)
At close: Oct 1, 2026 · 4:00 PM EDT

GT Biopharma (GTBP) Other Non-Current Liabilities (2022 - 2024)

Updated

GT Biopharma (GTBP) posted Other Non-Current Liabilities of $277,000 for Q2 2024, down 82.0% from $1.54 million a year earlier and down 29.7% from the prior quarter.

Analysis

GT Biopharma (GTBP) Other Non-Current Liabilities (2022 - 2024) Analysis & Trends

At the end of FY2023, GT Biopharma's Other Non-Current Liabilities came in at $1.05 million.

  • In prior years, GT Biopharma's Other Non-Current Liabilities was $19,000 in FY2022.
  • The Q2 2024 figure stands as the lowest quarterly Other Non-Current Liabilities since Q4 2022.
  • According to Business Quant data, Other Non-Current Liabilities for the three prior quarters was $394,000 (Q1 2024), $1.05 million (Q4 2023) and $1.1 million (Q3 2023).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 GT Biopharma 9.11 Mn 9.11 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2024 277,000.00
Mar 31, 2024 394,000.00
Dec 31, 2023 1.05 Mn
Sep 30, 2023 1.10 Mn
Jun 30, 2023 1.54 Mn
Mar 31, 2023 2.93 Mn
Dec 31, 2022 19,000.00
API Access

GT Biopharma Other Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=GTBP&period=max&api_key=YOUR_API_KEY